Dr. Tashko’s 3D infographic illustrating the relationship between heavy resistance training, hematocrit, and oxygen transport. A steel barbell appears suspended above a flowing stream of red blood cells, symbolizing erythrocyte production and circulation during testosterone therapy. Scientific molecular structures in the background reinforce endocrine physiology, while the imagery highlights the question of whether strength training influences TRT-associated increases in red blood cell volume and hematocrit.

Many men receiving testosterone replacement therapy (TRT) experience improved energy, body composition, and strength. Concurrently, physicians monitor hematocrit because testosterone stimulates red blood cell production, occasionally leading to erythrocytosis.

This raises an interesting question: if skeletal muscle uses testosterone for growth and repair, could heavy resistance training act as a metabolic sink? Could working muscles divert testosterone away from the bone marrow, thereby reducing the rise in hematocrit?

The concept is elegant. It creates an appealing mental picture of working muscles pulling testosterone toward themselves, leaving less hormone available to stimulate red blood cell production. Unfortunately, human physiology operates differently.

Testosterone Is Not a Fixed Resource

The hypothesis fails because testosterone does not function like a limited fuel tank. Instead, it circulates continuously. Exogenous testosterone creates systemic exposure that remains substantially higher and more sustained than the body’s natural pulsatile secretion.

Although resistance training increases androgen receptor activity within skeletal muscle, this does not deprive other tissues of hormone exposure. The kidneys, liver, and bone marrow continue to encounter sufficient testosterone concentrations to activate their own biologic responses. Hard-working muscles do not starve the bone marrow of testosterone.

The Mechanisms of Erythrocytosis

Testosterone increases hematocrit through three overlapping mechanisms:

  • Direct Bone Marrow Stimulation: Testosterone directly stimulates erythroid precursor cells, which mature into red blood cells.
  • Increased Erythropoietin: Testosterone increases erythropoietin (EPO) production in the kidneys, a major signal for red blood cell synthesis.
  • Hepcidin Suppression: The most critical mechanism involves hepcidin, a liver-produced hormone regulating iron availability. Testosterone strongly suppresses hepcidin, increasing intestinal iron absorption and mobilizing stored iron. Consequently, the bone marrow gains the iron required for hemoglobin synthesis. Heavy resistance training does not interrupt this pathway.

How TRT Raises Hematocrit

MechanismPrimary Organ/SystemEffect on Red Blood Cell Production
Direct Bone Marrow StimulationBone MarrowStimulates erythroid precursor cells to produce more red blood cells
Increased Erythropoietin (EPO)KidneysIncreases the hormonal signal that drives red blood cell production
Hepcidin SuppressionLiver and Iron MetabolismIncreases iron availability for hemoglobin synthesis and erythropoiesis
Effect of Heavy WeightliftingSkeletal MuscleImproves strength and metabolic health but does not block the above pathways

Why Lifters Sometimes Show Higher Hematocrit

In clinical practice, heavy lifters do not consistently demonstrate lower hematocrit levels than sedentary individuals on TRT. Sometimes, their values appear slightly higher due to:

  • Plasma Volume Shifts: Intense training drives fluid from the bloodstream into active muscle tissue (the pump). This temporarily concentrates red blood cells, artificially elevating measured hematocrit.
  • Hydration Status: Hematocrit is a percentage. Inadequate hydration reduces plasma volume, thereby increasing the hematocrit percentage without a true rise in red blood cell mass. To ensure accurate readings, schedule blood draws on rest days and maintain proper hydration.

Determining Erythrocytosis Risk

The risk of TRT-induced erythrocytosis depends primarily on systemic factors, including testosterone dose, administration route, genetic susceptibility, sleep apnea, smoking status, and altitude exposure. Intramuscular injections generally carry a higher risk than transdermal preparations because they produce larger concentration peaks.

The Physiologic Reality

Many biological systems compete for resources, making it tempting to imagine growing muscle shielding other tissues from testosterone. Yet, hormones function as a distributed signaling network. Multiple tissues receive the same message simultaneously.

Heavy resistance training undoubtedly improves metabolic health and muscular function. However, muscle and bone marrow do not compete for testosterone. They respond to the same systemic hormonal signal through entirely different physiologic pathways. Consequently, the mechanisms driving TRT-induced erythrocytosis remain intact, driven by systemic hormone exposure and individual biologic susceptibility rather than muscular exertion.

Dr. Tashko

  1. Seasonal Variation of Red Blood Cell Variables in Physically Inactive Men: Effects of Strength Training. International Journal of Sports Medicine. 2008. Hu M, Finni T, Sedliak M, et al.
  2. Red Blood Cells in Sports: Effects of Exercise and Training on Oxygen Supply by Red Blood Cells. Frontiers in Physiology. 2013. Mairbäurl H.
  3. Regulation of Red Blood Cell Volume With Exercise Training. Comprehensive Physiology. 2018. Montero D, Lundby C.
  4. Hematological Indices and Iron Status in Athletes of Various Sports and Performances. Medicine and Science in Sports and Exercise. 2002. Schumacher YO, Schmid A, Grathwohl D, Bültermann D, Berg A.
  5. Haematological Actions of Androgens. Best Practice & Research. Clinical Endocrinology & Metabolism. 2022. Warren AM, Grossmann M.
  6. Risks of Testosterone-Replacement Therapy and Recommendations for Monitoring. The New England Journal of Medicine. 2004. Rhoden EL, Morgentaler A.
  7. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology and Metabolism. 2018. Bhasin S, Brito JP, Cunningham GR, et al.
  8. JAK2 Unmutated Erythrocytosis: 2026 Update on Diagnosis and Management. American Journal of Hematology. 2025. Gangat N, Szuber N, Tefferi A.
  9. Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long-Term Follow-Up Study on Prevalence, Determinants, and Exposure Years. The Journal of Clinical Endocrinology and Metabolism. 2021. Madsen MC, van Dijk D, Wiepjes CM, et al.

About Dr. Gerti Tashko, MD

Dr. Gerti Tashko, MD, is an endocrinologist in Montgomery County, Maryland. He is uniquely quadruple board-certified in endocrinology, lipidology, hypertension, and obesity medicine. His practice delivers root-cause-focused metabolic and endocrine care, available virtually and in person. He uses advanced diagnostics, personalized nutrition, and preventive medicine to improve long-term health.